Simon Draper

Professor of Vaccinology and Translational Medicine @UniofOxford | Views own

[Simon Draper @S1monJDraper]

Exciting data from a human malaria re-challenge model deciphering how humans become immunologically tolerant to falciparum #malaria. Big thanks to fantastic collaborators @spence_lab.

[Journal of Experimental Medicine @JExpMed]

Muñoz Sandoval, Bach, Nahrendorf, Spence et al. @EdinburghUni show that a single #malaria episode reprograms T cell activation to minimize cytotoxicity and injury during subsequent infections. https://t.co/PZQeOgYi1E

@S1monJDraper

[British Society for Immunology @britsocimm]

Thanks to global immunisation efforts, an estimated 154 million lives have been saved over the past 50 years 🌎 🤝

That’s equivalent to 6 lives every minute.

#CelebrateVaccines

[OptiVivax @OptiVivax]

Great podcast by Andrew Duncan explaining our latest P. vivax malaria challenge clinical trial. Part of the #OptiVivax Consortium working with the @OxfordVacGroup and @KavliOxford
https://t.co/5RhF6Na6Dg
@OxPaediatrics @OxfordMedSci @UniofOxford @KavliFoundation

[OptiVivax @OptiVivax]

#OptiViVax launches a first-in-kind clinical trial, BIO-006, with the @OxfordVacGroup to investigate relapsing malaria infection caused by Plasmodium vivax.

Find out more here: https://t.co/i0RPXCGP22

@KavliOxford @OxfordMedSci @UniofOxford @KavliFoundation @OxPaediatrics

[Simon Draper @S1monJDraper]

@KavliOxford @OptiVivax

[Medical Sciences @OxfordMedSci]

VOLUNTEER OPPORTUNITY - Healthy volunteers needed to take part in a pioneering malaria challenge study to help us find out more about relapsing malaria infections.

Join the fight against malaria with us! @OxfordVacGroup @BiochemOxford

Find out more👇
https://t.co/UpdVA22U8p

[Simon Draper @S1monJDraper]

Our group's new BIO-006 clinical trial on #vivax #malaria is recruiting now in Oxford. The first trial in our @OptiVivax consortium. Aiming to assess relapsing malaria infection - check out the link below 👇

[Oxford Vaccine Group @OxfordVacGroup]

NEW | The Oxford Vaccine Group has launched a novel clinical study, BIO-006, to investigate relapsing malaria infections caused by Plasmodium vivax.

This unique parasite can remain dormant in the liver for months or years, reactivating to cause repeated malaria infections.

[EMBL Events @EMBLEvents]

📢 Sign up for BioMalPar XXI and join us in this crucial endeavour to understand the biology of the malaria parasite and to advance global health 🌍⚕️#EMBLMalaria

👉🏻 https://t.co/FI18FrnAFU

Topics
🦟 Epidemiology
🦟 Vaccines & immunity
🦟 Vector & transmission
🦟 Molecular & cellular biology
🦟 Drug targets & resistance

📅 20 – 22 May 2025
📍 EMBL Heidelberg and Virtual
📝 Submit your abstract by 25 Feb!

[EMBL Events @EMBLEvents]

🦟 #Malaria remains a major global health challenge, with rising deaths and drug resistance adding urgency to the fight.

🌍🤝 Join us for the 21st edition of #EMBLMalaria as we strengthen partnerships, share insights, and drive innovations to combat malaria's toll and advance global health 👉🏻 https://t.co/FI18Fro8vs

'BioMalPar XXI: biology and pathology of the malaria parasite'
📅 20 – 22 May 2025
📍 EMBL Heidelberg and Virtual
📝 Submit your abstract by 25 Feb

@lilimancio

[Medical Sciences @OxfordMedSci]

NEWS: First vaccine against blood-stage malaria is well-tolerated and offers effective protection

The study showed that the new vaccine (RH5.1/Matrix-MTM) was well tolerated with no safety concerns, working by reducing the parasite level in the blood.

https://t.co/Fdvh19oQNR

[Simon Draper @S1monJDraper]

Big thanks to funders and support from @EDCTP, @USAID, #NIAID, @KavliOxford, @BiochemOxford, @JennerInstitute, @The_MRC, @wellcometrust, @OxfordBRC, and @OxPaediatrics.

[Simon Draper @S1monJDraper]

Delighted to share our first safety and efficacy data on the RH5.1/Matrix-M blood-stage #malaria #vaccine in 5-17 month old children in Burkina Faso published @TheLancetInfDis. https://t.co/G8FfgCUS3q

[Simon Draper @S1monJDraper]

Big congrats to H. Magloire Natama, Jo Salkeld, Sarah Silk, @halidou_tinto and Angela Minassian and all the teams who have supported this work @UniofOxford, @URCNNanoro, #NIAID, @LSHTM, @SerumInstIndia, @Novavax, and @ExpreS2ionB.

[LSHTM_malaria @LSHTM_malaria]

Ahead of his retirement lecture today, we celebrate the extraordinary career of Professor Sir Brian Greenwood, a pioneer in global health and malaria research.

Read more about his remarkable contributions👇
https://t.co/nDHfEV0DSX

[ICPvR 2025 @icpvr2025]

The French Riviera of the East beckons!!
Come, join us for the 9th ICPvR, hosted by ICMR-VCRC.

[International Society for Vaccines (ISV) @Int_S_Vaccines]

🎙️ISV Global Webinar Series
👉6th December 2024 
07:00 (PST) | 1:00 (EST) | 17:00 (South Africa) | 20:30 (IST) 


Title: "Vaccines against Outbreak Pathogens - what next?" by Dr Teresa Lambe @jenneratingVacc @UniofOxford
👉Join us: https://t.co/fKSv6HP7aw

[Institut Pasteur Education @PasteurEdu]

🦟Exciting News! Registrations are now open for the Malaria MOOC!
👉 Enroll Now : https://t.co/eHltUwDrPp
The MOOC provides an overview of malaria today, from the cellular biology of the parasite to treatments, from immune response to control and elimination strategies.

[Department of Biochemistry at Oxford University @BiochemOxford]

PREVENTION: The Invisible Future of Health - Sir Andrew Pollard
The 17th Unither Baruch Blumberg Lecture
4:30pm Wednesday 13th November 2024 Oxford University Museum of Natural History Parks Road, Oxford OX1 3PW

[Simon Draper @S1monJDraper]

Big congrats to @TheBeiLab, @LatyGaye and their team on the first analysis of #RH5 blood-stage #malaria human #mAbs against P. falciparum clinical isolates in Senegal. Encouraging for strain-transcendence. Check out their great paper @Nature_NPJ below👇

[Amy Kristine Bei @TheBeiLab]

So excited for this paper to be published, proud of the amazing hard work that went into it, and so grateful for the amazing collaborations that made it all possible! You can get a glimpse “behind the paper” here: https://t.co/ku2LE1VNnW. Stay tuned for Laty’s thread!

[Zero Malaria @ZeroMalaria]

"Malaria is as old as Egyptian civilization itself, but the disease that plagued pharaohs now belongs to its history and not its future." - @DrTedros @WHO

YES! Congratulations go out to 🇪🇬 EGYPT on being certified #ZeroMalaria 👏